bezafibrate has been researched along with Menopause in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguila, MB; Correia, AL; dos Anjos, TL; Faria, Tda S; Mandarim-de-Lacerda, CA | 1 |
| Cramb, R; Florkowski, CM; Hughes, EA; Jones, AF | 1 |
2 other study(ies) available for bezafibrate and Menopause
| Article | Year |
|---|---|
Adverse association between obesity and menopause in mice treated with bezafibrate, a pan peroxisome proliferator-activated receptor agonist.
Topics: Adiposity; Animals; Bezafibrate; Diet, High-Fat; Female; Hypolipidemic Agents; Islets of Langerhans; Menopause; Mice; Mice, Inbred C57BL; Obesity; Ovariectomy; Peroxisome Proliferator-Activated Receptors | 2013 |
Bezafibrate in the treatment of hypercholesterolaemia in post-menopausal women.
Topics: Adult; Aged; Bezafibrate; Coronary Disease; Female; Humans; Hypercholesterolemia; Menopause; Middle Aged | 1990 |